Aaron Rosenberg - Mar 5, 2025 Form 4 Insider Report for BeiGene, Ltd. (BGNE)

Role
Chief Financial Officer
Signature
/s/ Qing Nian, as Attorney-in-Fact
Stock symbol
BGNE
Transactions as of
Mar 5, 2025
Transactions value $
$0
Form type
4
Date filed
3/7/2025, 07:19 PM
Previous filing
Aug 13, 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BGNE Ordinary Shares Award $0 +48.6K +40.98% $0.00 167K Mar 5, 2025 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents the total number of ordinary shares underlying the performance share units earned by Reporting Person. The earned performance share units will vest in 2027, subject to the Reporting Person continuing to provide service to the Company through such vesting date. Unvested securities are subject to accelerated vesting upon certain termination events.